Clinical and Biochemical Potential of Antioxidants in Treating Polycystic Ovary Syndrome

Abstract

Xiangyi Cheng, Bing He Department of Endocrinology, Shengjing Hospital, China Medical University, Shenyang, Liaoning Province, People’s Republic of ChinaCorrespondence: Bing He, Department of Endocrinology, Shengjing Hospital, China Medical University, Shenyang, 110000, Liaoning Province, People’s Republic of China, Email [email protected]: Polycystic ovary syndrome (PCOS) is the most common cause of infertility in reproductive-age women. Increased reactive oxygen species levels and decreased antioxidant capacity in PCOS patients can lead to metabolic disorders and damage the ovarian tissues, resulting in the occurrence of related symptoms. Antioxidants have been used in the treatment of PCOS and have yielded satisfactory outcomes due to their ability to counter oxidative stress. Many experiments on PCOS patients have proved that antioxidants can not only improve the ovarian environment, promote follicular maturation, and elevate oocyte quantities but can also regulate lipid and glucose metabolism as well as vascular endothelial cell function in PCOS patients, thereby attenuating adiposity and reducing the occurrence rate of chronic complications to ensure that patients can obtain long-term benefits. This review describes the use of antioxidants in PCOS, which have been used in the treatment.Keywords: PCOS, oxidative stress, antioxidants, α-lipoic acid

Keywords

• pcos
• oxidative stress
• antioxidants
• α-lipoic acid